Boya Bio-pharmaceutical (300294)
Overview
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the research, development, production, and sale of blood products in China. It offers blood products, such as human serum albumin; human, intravenous, freeze-dried intravenous, hepatitis B, tetanus, and rabies immunoglobulin; and human fibrinogen, prothrombin complex, and coagulation factor VIII. The company also provides compound bone peptide, oxytocin, heparin sodium injection, posterior pituitary, and carboprost tromethamine inj
Employees1947
Market Cap$8.2B
Revenue$1.8B
Listed OnShenzhen Stock Exchange
Ticker300294
CEOMr. Yuxuan Pan
HeadquartersFuzhou